EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Stimulatory effect of imeglimin on incretin secretion

Quan Yingyue, Kenji Sugawara iD, Harumi Takahashi, Norihide Yokoi iD, Kento Ohbayashi, Yusaku Iwasaki, Susumu Seino iD, Wataru Ogawa iD

Journal of Diabetes Investigation · 2023

DOI: 10.1111/jdi.14001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2023. Verfasst von Quan Yingyue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Incretins, Blood Glucose. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science KAKENHI, Sumitomo Pharma Co. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction Imeglimin is a new antidiabetic drug structurally related to metformin. Despite this structural similarity, only imeglimin augments glucose‐stimulated insulin secretion (GSIS), with the mechanism underlying this effect remaining unclear. Given that glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) also enhance GSIS, we examined whether these incretin hormones might contribute to the pharmacological actions of imeglimin. Materials and Methods Blood glucose and plasma insulin, GIP, and GLP‐1 concentrations were measured during an oral glucose tolerance test (OGTT) performed in C57BL/6JJcl (C57BL/6) or KK‐Ay/TaJcl (KK‐Ay) mice after administration of a single dose of imeglimin with or without the dipeptidyl peptidase‐4 inhibitor sitagliptin or the GLP‐1 receptor antagonist exendin‐9. The effects of imeglimin, with or without GIP or GLP‐1, on GSIS were examined in C57BL/6 mouse islets.

Results

Imeglimin lowered blood glucose and increased plasma insulin levels during an OGTT in both C57BL/6 and KK‐Ay mice, whereas it also increased the plasma levels of GIP and GLP‐1 in KK‐Ay mice and the GLP‐1 levels in C57BL/6 mice. The combination of imeglimin and sitagliptin increased plasma insulin and GLP‐1 levels during the OGTT in KK‐Ay mice to a markedly greater extent than did either drug alone. Imeglimin enhanced GSIS in an additive manner with GLP‐1, but not with GIP, in mouse islets. Exendin‐9 had only a minor inhibitory effect on the glucose‐lowering action of imeglimin during the OGTT in KK‐Ay mice.

Conclusions

Our data suggest that the imeglimin‐induced increase in plasma GLP‐1 levels likely contributes at least in part to its stimulatory effect on insulin secretion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsBlood GlucoseAnimalsMiceInsulinMice, Inbred C57BLSitagliptin PhosphateHypoglycemic AgentsGlucoseGlucagon-Like Peptide 1Gastric Inhibitory PolypeptideTriazines

Stichwörter der Autor:innen

Glucagon-like peptide-1Glucose-stimulated insulin secretionImeglimin

Substanzen

IncretinsBlood GlucoseInsulinSitagliptin PhosphateHypoglycemic AgentsGlucoseGlucagon-Like Peptide 1Gastric Inhibitory PolypeptideimegliminTriazines

Autor:innen und Institutionen

  • Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Laboratory of Animal Breeding and Genetics, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
  • Laboratory of Animal Science, Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Japan.

ORCID-Profile: Kenji Sugawara, Norihide Yokoi, Susumu Seino, Wataru Ogawa

Förderung

  • Japan Society for the Promotion of Science KAKENHI
  • Sumitomo Pharma Co. Ltd.

Zitieren

APA

Yingyue, Q., Sugawara, K., Takahashi, H., Yokoi, N., Ohbayashi, K., Iwasaki, Y., Seino, S., & Ogawa, W. (2023). Stimulatory effect of imeglimin on incretin secretion. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14001

Vancouver

Yingyue Q, Sugawara K, Takahashi H, Yokoi N, Ohbayashi K, Iwasaki Y, et al. Stimulatory effect of imeglimin on incretin secretion. Journal of Diabetes Investigation. 2023. doi:10.1111/jdi.14001

BibTeX
@article{Yingyue2023,
  author = {Yingyue, Quan and Sugawara, Kenji and Takahashi, Harumi and Yokoi, Norihide and Ohbayashi, Kento and Iwasaki, Yusaku and Seino, Susumu and Ogawa, Wataru},
  title = {Stimulatory effect of imeglimin on incretin secretion},
  journal = {Journal of Diabetes Investigation},
  year = {2023},
  doi = {10.1111/jdi.14001}
}
Kostenlos starten →